MPO and anti-neutrophil cytoplasmic antibody-associated vasculitis: In Japanese patients with MPO‐ANCA‐associated vasculitis (JMAAV), a refractory vasculitis study group determined the efficacy of a severity‐based treatment protocol for MPO‐ANCA‐positive AAV (MPO‐AAV) [10].